Biguanide and dihydrotriazine derivatives, preferably substituted asymmetrical imidodicarbonimidic diamides derived from hydroxylamines, and compositions containing biguanide and dihydrotriazine derivatives are disclosed. In addition, methods of using the biguanide and dihydrotriazine derivatives, inter alia, as antimicrobial agents and methods of using the dihydrotriazine derivatives in biological assays are disclosed. Methods of making the biguanide and dihydrotriazine derivatives are also disclosed.
本文披露了biguanide和dihydrotriazine衍
生物,其中首选的是从
羟胺衍生的取代不对称imidodicarbonimidic二
酰胺,以及含有biguanide和dihydrotriazine衍
生物的组合物。此外,本文还披露了使用biguanide和dihydrotriazine衍
生物的方法,包括作为抗微
生物剂的方法,以及使用dihydrotriazine衍
生物进行
生物测定的方法。本文还披露了制备biguanide和dihydrotriazine衍
生物的方法。